Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling hungry on Wegovy is more common than most people expect, and it doesn't mean the medicine isn't working. Semaglutide reduces appetite for most people, but hunger doesn't vanish completely — many find it shifts in character rather than disappearing. That's a meaningful difference, and understanding it can change how you manage the weeks ahead. Wegovy is a prescription-only medicine; a clinician assesses whether it's right for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a scenario our prescribers hear often. The first weeks on Wegovy tend to bring noticeable nausea and a real drop in appetite, and then, as your body adjusts, the nausea fades and hunger edges back. It can feel like the medicine has stopped working. It almost certainly hasn't.
What's happened is that the acute side-effect phase has passed and your system has recalibrated to the current dose. Wegovy's active ingredient, semaglutide, works partly by slowing how quickly food leaves your stomach and partly by acting on appetite-regulating receptors in the brain. Both effects are dose-dependent. At 0.25 mg and 0.5 mg (the early titration steps) those effects are present but relatively modest. Hunger tends to reduce more substantially at the 1.7 mg and 2.4 mg maintenance doses, which most people reach after around four months of step-wise increases. If you're hungry now, you may simply not be at the dose where semaglutide has its fuller effect yet. The NHS medicines page for semaglutide describes this titration pattern clearly and is worth bookmarking for reference alongside your Patient Information Leaflet.
One thing worth letting go: the idea that hunger on Wegovy means you lack willpower or are doing something wrong. Hunger is a biological signal shaped by hormones, sleep, stress and habit, it's not a character flaw. The medicine works with those systems, not around them, and the timeline is individual.
If you're curious how other people navigate this in the longer term, the broader picture of hunger and Wegovy covers common patterns across different stages of treatment.
Here's something that surprises a lot of people: Wegovy tends to reduce physical, stomach-empty hunger more effectively than it reduces the urge to eat out of habit, boredom or emotion. You might feel completely full after a small meal and still find yourself reaching for a snack at 9pm because that's what you've always done.
These are different things. Physical hunger is driven by ghrelin and other gut hormones that semaglutide influences directly. Habitual or reward-driven eating is wired into routine and mood. Both feel like hunger. Distinguishing them (noticing whether the sensation is in your stomach or your head) is one of the most practically useful things you can do during treatment, and it's something worth raising with your prescriber if you're finding it hard to tell the difference.
Protein and fibre both slow stomach emptying and prolong the feeling of fullness, which means what you eat matters as much as how much. If you want a practical framework for eating alongside treatment, our guide to what to eat on Wegovy covers the evidence-based basics without being prescriptive about portions or calories.
For a deeper look at whether hunger on semaglutide more broadly is to be expected, the question of hunger on semaglutide explores what the clinical data actually shows about appetite suppression across doses.
Most hunger on Wegovy resolves as the dose increases and your body adapts. But there are patterns that are worth flagging to your prescriber rather than waiting out.
If your hunger has not reduced at all across several consecutive doses, or if you're losing weight at a much slower rate than expected, a clinical conversation makes sense. It's possible the dose isn't yet at a therapeutic level for you, or that another factor (disrupted sleep, high stress, certain medicines) is working against appetite suppression. Prescribers can review the picture and adjust accordingly.
Separately, if you're experiencing significant nausea alongside ongoing hunger, that combination can sometimes indicate the titration pace needs revisiting. Nausea that interferes with eating isn't the same as healthy appetite reduction, and it's not something to simply push through. The MHRA's Yellow Card scheme is there for reporting unexpected or troubling side effects, and your prescriber should always be the first call for anything that concerns you.
Wondering what the experience looks like for people further into treatment? The question of still feeling hungry later on Wegovy addresses what happens when appetite reduction is slower than expected.
Hunger is one of many things worth monitoring and discussing as treatment progresses. Wegovy works best alongside sustainable changes to eating habits and physical activity, not because the medicine won't work otherwise, but because those changes compound what the medicine does. Many people find their relationship with food shifts considerably over months, in ways that go beyond the scale.
If you're not yet on Wegovy and are thinking about whether it's right for you, the Wegovy overview page covers eligibility, how treatment works and what to expect from the titration schedule. The weight-loss treatment overview compares the options side by side if you're still weighing things up.
Treatment cost is a reasonable practical question at this stage. The Wegovy cost page sets out what a private prescription realistically involves and what's included in a transparent price.
When you're ready to see whether treatment is clinically suitable, our prescribers review every consultation personally. Check your eligibility with a free consultation, there's no obligation, and the clinical review happens the same day you apply.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.